A thorough QTC study to assess the effect of Cotadutide on cardiac repolarization in healthy participants

Trial Identifier: D5671C00010
Sponsor: AstraZeneca
NCTID:: NCT05668936
Start Date: January 2023
Primary Completion Date: March 2023
Study Completion Date: March 2023

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Version
German Translation

Trial Locations

Country Location
DE Berlin, DE, 14050